Single dose of a rVSV-based vaccine elicits complete protection against severe fever with thrombocytopenia syndrome virus

Severe fever with thrombocytopenia virus is an emerging tick-borne arbovirus first reported in East and Central China in 2009, and subsequently in Korea and Japan. A closely related virus, termed Heartland virus, was identified and isolated from two patients in the US in 2012.

Influenza H5/H7 Virus Vaccination in Poultry and Reduction of Zoonotic Infections, Guangdong Province, China, 2017–18

Researchers compared the detection frequency of avian influenza H7 subtypes at live poultry markets in Guangdong Province, China, before and after the introduction of a bivalent H5/H7 vaccine in poultry. The vaccine was associated with a 92 percent reduction in H7 positivity rates among poultry and a 98 percent reduction in human H7N9 cases.

Democratic Republic of the Congo begins first-ever multi-drug Ebola trial

The Ministry of Health of the Democratic Republic of the Congo (DRC) announced, November 26, that a randomized control trial has begun to evaluate the effectiveness and safety of drugs used in the treatment of Ebola patients. The trial will form part of a multi-outbreak, multi-country study that was agreed to by partners under a World Health Organization (WHO) initiative.